Insight Molecular director shares withheld for taxes

Insight Molecular Diagnostics Inc. director Lou Silverman reported a routine tax-related share disposition.

Rhea-AI Filing Summary

Insight Molecular Diagnostics Inc. director Lou Silverman reported a routine tax-related share disposition. On July 1, 2026, 7,700 shares of common stock valued at $5.69 per share were withheld by the company to cover tax obligations from the vesting of 35,000 restricted stock units granted on July 1, 2025. The footnote clarifies that Silverman did not sell any shares in the market, and he now directly holds 55,807 shares after this withholding.

Insider Trade Summary

Exercise Price or Tax Liability: 7,700 shares

Exercise Price or Tax Liability 1 txn

Insider SILVERMAN LOU

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, no par value	7,700	$5.69	$44K

Holdings After Transaction: Common Stock, no par value — 55,807 shares (Direct)

Footnotes (1)

1. F1. The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

Key Figures

Tax-withheld shares: 7,700 shares Per-share value for withholding: $5.69 per share Shares held after transaction: 55,807 shares +1 more

4 metrics

Tax-withheld shares 7,700 shares Shares withheld to cover tax obligations on vesting RSUs on July 1, 2026

Per-share value for withholding $5.69 per share Value based on Nasdaq Capital Market price on vesting date

Shares held after transaction 55,807 shares Direct IMDX common stock holdings after tax-withholding disposition

Vesting RSUs 35,000 units Restricted stock units granted July 1, 2025 that vested July 1, 2026

Key Terms

restricted stock units, tax withholding obligations, Nasdaq Capital Market

3 terms

restricted stock units financial

"the vesting of 35,000 shares of restricted stock units granted to the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting"

Nasdaq Capital Market market

"price per share on the date on which the shares vested as reported on the Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Insight Molecular (IMDX) director Lou Silverman report in this Form 4?

Lou Silverman reported that 7,700 IMDX shares were withheld to cover tax obligations from vesting restricted stock units. This was a non-market, tax-withholding disposition, not an open-market sale, and it adjusted his direct holdings without reflecting a discretionary trading decision.

Did Lou Silverman sell Insight Molecular (IMDX) shares in the open market?

No, the filing explicitly states Silverman did not sell any shares. Instead, 7,700 shares were withheld by the company to satisfy tax withholding obligations tied to vesting restricted stock units, a common administrative process rather than a discretionary buy or sell transaction.

How many Insight Molecular (IMDX) shares were withheld for taxes and at what value?

A total of 7,700 IMDX common shares were withheld to cover tax obligations. The withholding used a per-share value of $5.69, matching the share price on the vesting date as reported on the Nasdaq Capital Market, according to the footnote.

What equity award caused the tax withholding for Lou Silverman at Insight Molecular (IMDX)?

The tax withholding arose from the vesting of 35,000 restricted stock units granted to Lou Silverman on July 1, 2025. When these units vested on July 1, 2026, the company withheld 7,700 shares to satisfy associated tax obligations instead of requiring a separate cash payment.

How many Insight Molecular (IMDX) shares does Lou Silverman hold after this transaction?

After the tax-withholding disposition, Silverman directly holds 55,807 IMDX common shares. This figure, reported in the Form 4, reflects his updated ownership position following the withholding of 7,700 shares used to cover tax obligations related to the vesting restricted stock units.

What type of transaction code was used in Lou Silverman’s IMDX Form 4?

The Form 4 uses transaction code “F,” indicating shares delivered or withheld to pay an exercise price or tax liability. Here, it specifically reflects shares withheld by the issuer for tax obligations on vesting restricted stock units, not a typical open-market sale transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 08:40 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SILVERMAN LOU

(Last) (First) (Middle)

C/O INSIGHT MOLECULAR DIAGNOSTICS INC.

2 INTERNATIONAL PLAZA, SUITE 510

(Street)

NASHVILLE TENNESSEE 37217

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Insight Molecular Diagnostics Inc. [ IMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, no par value(1)	07/01/2026		F		7,700	D	$5.69	55,807	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Louis E. Silverman	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)